Colorado Medicaid and tirzepatide
Zepbound for weight loss: no. Prior authorization for adults with moderate to severe sleep apnea and BMI 30 or higher, after a CPAP trial or with a reason CPAP cannot be used. Mounjaro for weight loss: no; for type 2 diabetes Colorado Medicaid must cover it. Read from Colorado Department of Health Care Policy and Financing documents Nov 6, 2026.
In 2025 Colorado Medicaid paid for 32,029 tirzepatide prescriptions (Mounjaro, Zepbound), 26% of its GLP-1 prescriptions and 19th of the 50 states and DC. It reimbursed $32.8 million before rebates, $1,026 a prescription against $1,032 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Mounjaro | 24,586 | $26.1 million | $1,061 |
| Zepbound | 7,443 | $6.8 million | $909 |
Colorado plans and prescribing rules
State of Colorado employee health plan. Colorado restored state employee coverage of GLP-1s for weight loss on May 1, 2026, through its GLP-1 Benefit 360 Program. Members on the Cigna plan get Zepbound for weight loss unless another drug is medically necessary.
Tirzepatide in the states around Colorado
| State | Sell tirzepatide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Zepbound for weight loss |
|---|---|---|---|---|
| Colorado | 17 | $69/moWellmedr | 32,029 | Medicaid Zepbound: No |
| Arizona | 17 | $69/moWellmedr | 6,126 | Medicaid Zepbound: Unclear |
| Kansas | 17 | $69/moWellmedr | 34,414 | Medicaid Zepbound: Yes |
| Nebraska | 17 | $69/moWellmedr | 6,041 | Medicaid Zepbound: No |
| New Mexico | 17 | $69/moWellmedr | 18,921 | Medicaid Zepbound: No |
| Oklahoma | 17 | $69/moWellmedr | 13,923 | Medicaid Zepbound: No |
| Utah | 17 | $69/moWellmedr | 8,455 | Medicaid Zepbound: Not confirmed (KFF) |
| Wyoming | 17 | $69/moWellmedr | 738 | Medicaid Zepbound: No |



